두경부 영역의 방사선치료와 그에 따른 정상조직 변화

키워드

참고문헌 (59)

1. Borras JM, "The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project", Radiother Oncol, 116, pp.45~50 (2015)[DOI]
2. Browman GP, "Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer", J Clin Oncol, 12, pp.2648~2653 (1994)[DOI]
3. Al-Sarraf M, "Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099", J Clin Oncol, 16, pp.1310~1317 (1998)[DOI]
4. Adelstein DJ, "Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: An Eastern Cooperative Oncology Group pilot study", J Clin Oncol, 11, pp.2136~2142 (1993)[DOI]
5. Brizel DM, "Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer", N Engl J Med, 338, pp.1798~1804 (1998)[DOI]
6. Bonner JA, "Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck", N Engl J Med, 354, pp.567~578 (2006)[DOI]
7. Bourhis J, "Hyperfractionated or accelerated radiotherapy in head and neck cancer: a metaanalysis", Lancet, 368, pp.843~854 (2006)[DOI]
8. Baujat B, "Hyperfractionated or accelerated radiotherapy for head and neck cancer", Cochrane Database Syst Rev, 12 (2010)
9. Dawson LA, "Image-guided radiotherapy: rationale, benefits, and limitations", Lancet Oncol, 7, pp.848~858 (2006)[DOI]
10. Moran JM, "Radiotherapy: what can be achieved by technical improvements in dose delivery?", Lancet Oncol, 6, pp.51~58 (2005)[DOI]
11. Ten Haken RK, "The clinical application of intensity-modulated radiation therapy", Semin. Radiat. Oncol., 16, pp.224~231 (2006)[DOI]
12. Easton DF, "Genome-wide association studies in cancer", Hum Mol Genet, 17, pp.R109~R115 (2008)[DOI]
13. O'Driscoll M, "The role of double-strand break repair - insights from human genetics", Nat Rev Genet, 7, pp.45~54 (2006)
14. Taylor RC, "Apoptosis: controlled demolition at the cellular level", Nat Rev Mol Cell Biol, 9, pp.231~241 (2008)[DOI]
15. Branzei D, "Regulation of DNA repair throughout the cell cycle", Nat Rev Mol Cell Biol, 9, pp.297~308 (2008)[DOI]
16. Mikkelsen RB, "Biological chemistry of reactive oxygen and nitrogen and radiationinduced signal transduction mechanisms", Oncogene, 22, pp.5734~5754 (2003)[DOI]
17. Robbins ME, "Pathogenic role of the renin-angiotensin system in modulating radiationinduced late effects", Int J Radiat Oncol Biol Phys, 64, pp.6~12 (2006)[DOI]
18. Olsson AK, "VEGF receptor signalling - in control of vascular function", Nat Rev Mol Cell Biol, 7, pp.359~371 (2006)[DOI]
19. Barnett GC, "Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype", Nat Rev Cancer, 9, pp.134~142 (2009)[DOI]
20. Straub JM, "Radiation-induced fibrosis: mechanisms and implications for therapy", J Cancer Res Clin Oncol, 141, pp.1985~1994 (2015)[DOI]
21. Bentzen SM, "Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology", Nat Rev Cancer, 6, pp.702~713 (2006)[DOI]
22. Xavier S, "Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone", J Biol Chem, 279, pp.15167~15176 (2004)[DOI]
23. Flechsig P, "LY2109761 attenuates radiation-induced pulmonary murine fibrosis via reversal of TGF-<TEX>${\beta}$<", TEX> and BMP-associated proinflammatory and proangiogenic signals, 2012, pp.18, 3616~3627
24. Jacobson G, "Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter", Int J Radiat Oncol Biol Phys, 85, pp.604~608 (2013)[DOI]
25. Chua DT, "A pilot study of pentoxifylline in the treatment of radiation-induced trismus", Am J Clin Oncol, 24, pp.366~369 (2001)[DOI]
26. "Int J Radiat Oncol Biol Phys", 1995, 1341~1346, 10.1016[DOI]
27. Langendijk JA, "Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy", J Clin Oncol, 26, pp.3770~3776 (2008)[DOI]
28. Strojan P, "Treatment of late sequelae after radiotherapy for head and neck cancer", Cancer Treat Rev, 59, pp.79~92 (2017)[DOI]
29. Maria OM, "Radiation-Induced Oral Mucositis", Front Oncol, 7, pp.89~ (2017)[DOI]
30. Trotti A, "Toxicity in head and neck cancer: a review of trends and issues", Int J Radiat Oncol Biol Phys, 47, pp.1~12 (2000)[DOI]
31. Sonis ST, "Pathobiology of oral mucositis: novel insights and opportunities", J Support Oncol, 5, pp.3~11 (2007)
32. Ps SK, "Radiation induced oral mucositis", Indian J Palliat Care, 15, pp.95~102 (2009)[DOI]
33. Elting LS, "Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies", Int J Radiat Oncol Biol Phys, 68, pp.1110~1120 (2007)[DOI]
34. Sonis ST, "Perspectives on cancer therapy- induced mucosal injury", Cancer, 100, pp.1995~2025 (2004)[DOI]
35. Jensen SB, "A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life", Support Care Cancer, 18, pp.1039~1060 (2010)[DOI]
36. Beetz I, "The Groningen Radiotherapy-Induced Xerostomia questionnaire:development and validation of a new questionnaire", Radiother Oncol, 97, pp.127~131 (2010)[DOI]
37. Hey J, "Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy", Int J Radiat Oncol Biol Phys, 75, pp.1475~1880 (2009)[DOI]
38. Guchelaar HJ, "Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment", Support Care Cancer, 5, pp.281~288 (1997)[DOI]
39. Wijers OB, "Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors", Head Neck, 24, pp.737~747 (2002)[DOI]
40. Nutting CM, "Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial", Lancet Oncol, 12, pp.127~136 (2011)[DOI]
41. Kam MK, "Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients", J Clin Oncol, 25, pp.4873~4879 (2007)[DOI]
42. Marks LB, "Use of normal tissue complication probability models in the clinic", Int J Radiat Oncol Biol Phys, 76, pp.S10~S19 (2010)[DOI]
43. Lee TF, "Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy", Radiother Oncol, 106, pp.352~358 (2013)[DOI]
44. Beetz I, "The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia", Acta Oncol, 53, pp.597~604 (2014)[DOI]
45. Roe JW, "Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?", Oral Oncol, 50, pp.1182~1187 (2014)[DOI]
46. Nguyen NP, "Impact of dysphagia on quality of life after treatment of head-and-neck cancer", Int J Radiat Oncol Biol Phys, 61, pp.772~778 (2005)[DOI]
47. Terrell JE, "Clinical predictors of quality of life in patients with head and neck cancer", Arch Otolaryngol Head Neck Surg, 130, pp.40~408 (2004)
48. King SN, "Pathophysiology of radiationinduced dysphagia in head and neck cancer", Dysphagia, 31, pp.339~351 (2016)[DOI]
49. Rutten H, "Longterm outcome and morbidity after treatment with accelerated radiotherapy and weekly cisplatin for locally advanced head-and-neck cancer: results of a multidisciplinary late morbidity clinic", Int J Radiat Oncol Biol Phys, 81, pp.923~929 (2011)[DOI]
50. Langendijk JA, "A predictive model for swallowing dysfunction after curative radiotherapy in head and neck cancer", Radiother Oncol, 90, pp.189~195 (2009)[DOI]
51. Eisbruch A, "Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?", Int J Radiat Oncol Biol Phys, 60, pp.1425~1439 (2004)[DOI]
52. Popovtzer A, "Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study", Radiother Oncol, 93, pp.510~515 (2009)[DOI]
53. Levendag PC, "Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship", Radiother Oncol, 85, pp.64~73 (2007)[DOI]
54. Christianen ME, "Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study", Radiother Oncol, 105, pp.107~114 (2012)[DOI]
55. Starmer HM, "The effect of radiation dose on swallowing: evaluation of aspiration and kinematics", Dysphagia, 30, pp.430~437 (2015)[DOI]
56. Russi EG, "Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology", Cancer Treat Rev, 38, pp.1033~1049 (2012)[DOI]
57. Christianen ME, "Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach", Radiother Oncol, 118, pp.298~303 (2016)[DOI]
58. Christianen ME, "Delineation of organs at risk involved in swallowing for radiotherapy treatment planning", Radiother Oncol, 101, pp.394~402 (2011)[DOI]
59. Petkar I, "DARS: a phase III randomised multicentre study of dysphagia-optimised intensity-modulated radiotherapy (Do-IMRT) versus standard intensity-modulated radiotherapy (S-IMRT) in head and neck cancer", BMC Cancer, 16, pp.770~ (2016)[DOI]

관련 논문AI추천